» Articles » PMID: 37134064

Voxel Based Morphometry-detected White Matter Volume Loss After Multi-modality Treatment in High Grade Glioma Patients

Overview
Journal PLoS One
Date 2023 May 3
PMID 37134064
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Radiotherapy (RT) and chemotherapy are components of standard multi-modality treatment of high grade gliomas (HGG) aimed at achieving local tumor control. Treatment is neurotoxic and RT plays an important role in this, inducing damage even distant to the RT target volume.

Purpose: This retrospective longitudinal study evaluated the effect of treatment on white matter and gray matter volume in the tumor-free hemisphere of HGG patients using voxel based morphometry (VBM).

Method: 3D T1-weighted MR images of 12 HGG patients at multiple timepoints during standard treatment were analyzed using VBM. Segmentation of white matter and gray matter of the tumor-free hemisphere was performed. Multiple general linear models were used to asses white matter and gray matter volumetric differences between time points. A mean RT dose map was created and compared to the VBM results.

Results: Diffuse loss of white matter volume, mainly throughout the frontal and parietal lobe, was found, grossly overlapping regions that received the highest RT dose. Significant loss of white matter was first noticed after three cycles of chemotherapy and persisted after the completion of standard treatment. No significant loss of white matter volume was observed between pre-RT and the first post-RT follow-up timepoint, indicating a delayed effect.

Conclusion: This study demonstrated diffuse and early-delayed decreases in white matter volume of the tumor-free hemisphere in HGG patients after standard treatment. White matter volume changes occurred mainly throughout the frontal and parietal lobe and grossly overlapped with areas that received the highest RT dose.

Citing Articles

Mapping glioma's impact on cognition: Insights from macrostructure, microstructure, and beyond.

Cayuela N, Izquierdo C, Vaquero L, Camara E, Bruna J, Simo M Neurooncol Adv. 2025; 7(1):vdaf003.

PMID: 39911704 PMC: 11795312. DOI: 10.1093/noajnl/vdaf003.


Deformation-based morphometry: a sensitive imaging approach to detect radiation-induced brain injury?.

Brunaud C, Valable S, Ropars G, Dwiri F, Naveau M, Toutain J Cancer Imaging. 2024; 24(1):95.

PMID: 39026377 PMC: 11256482. DOI: 10.1186/s40644-024-00736-1.


Longitudinal brain volumetrics in glioma survivors.

McDonald A, Murdaugh D, Heinzman K, Cardan R, Jacob J, Fiveash J J Neurosurg. 2024; 141(3):634-641.

PMID: 38669700 PMC: 11875424. DOI: 10.3171/2024.1.JNS231980.

References
1.
Ashburner J, Friston K . Voxel-based morphometry--the methods. Neuroimage. 2000; 11(6 Pt 1):805-21. DOI: 10.1006/nimg.2000.0582. View

2.
Karunamuni R, Bartsch H, White N, Moiseenko V, Carmona R, Marshall D . Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma. Int J Radiat Oncol Biol Phys. 2016; 94(2):297-304. PMC: 4747044. DOI: 10.1016/j.ijrobp.2015.10.026. View

3.
Kitahara S, Nakasu S, Murata K, Sho K, Ito R . Evaluation of treatment-induced cerebral white matter injury by using diffusion-tensor MR imaging: initial experience. AJNR Am J Neuroradiol. 2005; 26(9):2200-6. PMC: 7976122. View

4.
Turnquist C, Harris B, Harris C . Radiation-induced brain injury: current concepts and therapeutic strategies targeting neuroinflammation. Neurooncol Adv. 2020; 2(1):vdaa057. PMC: 7271559. DOI: 10.1093/noajnl/vdaa057. View

5.
Postma T, Klein M, Verstappen C, Bromberg J, Swennen M, Langendijk J . Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology. 2002; 59(1):121-3. DOI: 10.1212/wnl.59.1.121. View